Learn, Analyse & Invest
only with
only with
+91
Download Orca
PCBL Chemical Ltd.
PCBL Chemical
₹ 0.00
0.00 (0.00)%
NSE
BSE
Chemicals
Small-cap - With a market cap of ₹113.99 Cr.
| EX-Date | Purpose |
|---|---|
| 21 04 2021 | Audited Results |
| 26 07 2021 | Quarterly Results |
| 27 08 2021 | Inter alia to consider and evaluate proposals for raising funds by way of issue of bonds/ debentures/ non-convertible debt instruments/ equity shares/ warrants/ any other securities, including through preferential issue on a private placement basis, qualified institutional placement, rights issue or any other methods or combination thereof, subject to approvals from the shareholders, stock exchanges and other regulatory/ governmental authorities, as may be required. |
| 27 10 2021 | Quarterly Results |
| 20 01 2022 | PCBL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2022 ,inter alia, to consider and approve Further to our letter dated 13th January, 2022, we write to inform you that in the Meeting of the Board of Directors of the Company to be held on 20th January, 2022, the Board will, inter-alia, consider a proposal for declaration of Interim Dividend for the financial year ending 31st March, 2022 and to fix Record Date for payment of the said Interim Dividend, if declared. We request you to take the above information on record. |
| 09 02 2022 | Stock Split |
| 19 04 2022 | Quarterly Results & Audited Results |
| 21 07 2022 | Quarterly Results |
| 26 10 2022 | Quarterly Results |
| 31 01 2023 | Quarterly Results & Interim Dividend |
| 15 05 2023 | Audited Results |
| 11 07 2023 | Quarterly Results |
| 17 10 2023 | Quarterly Results |
| 16 12 2023 | Inter alia, to consider and evaluate proposals for raising funds by way of issue of unlisted/listed, secured/unsecured, redeemable non-convertible debentures on private placement basis, or any other securities, or any other methods or combination thereof, for an amount as may be decided by the Board, subject to the borrowing limits of the Company and any other approvals from the shareholders, stock exchanges and other regulatory/governmental authorities, as may be required. |
| 15 01 2024 | Quarterly Results & Interim Dividend |
| 27 03 2024 | Inter alia, to consider and approve the proposal for raising of funds by way of issue of one or more instruments/ securities and determination of issue price thereof as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required including the approval of the Members of the Company. |
| 29 10 2024 | Quarterly Results |
| 10 01 2025 | Quarterly Results & Interim Dividend |
| 29 04 2025 | Audited Results |
| 23 07 2025 | Quarterly Results |
| 17 10 2025 | Quarterly Results & Interim Dividend |
| 03 02 2026 | Quarterly Results |
| 30 04 2026 | Audited Results |
News
